| TOVX 0.41 59.41% | FCHL 0.225 -37.22% | CTNT 0.0548 -42.50% | CMND 1.14 58.42% | BYND 1.16 41.02% | ENVB 3.65 100.55% | WLDS 1.3 -13.91% | TZA 5 -1.57% | LZMH 0.155 -10.71% | NVDA 202.06 0.19% | PLUG 3.22 15.83% | BITO 10.46 -1.60% | TSLL 13.29 -4.39% | INTC 65.7 -4.09% | ONDS 10.73 7.30% | NOK 10.61 2.91% | SOXS 18.63 -1.27% | BMNG 1.55 -3.13% | HIMS 31.01 7.60% | TQQQ 58.08 -0.87% | TSLA 392.5 -2.03% | NFLX 94.83 -2.55% | AAL 12.24 -4.23% | FRMI 5.4 -17.56% | SLNH 1.4 23.89% | BB 5.5 13.17% | NVD 5.59 -0.53% | QXO 24.22 -3.12% | SOFI 19.5 0.36% | SPDN 9.14 0.11% | IONQ 48.32 4.84% | SOXL 95.94 1.33% | SNAP 6 -0.50% | ATAI 4.9 21.59% | GRAB 4.21 0.00% | SQQQ 56.91 0.92% | POET 8.59 18.32% | SIDU 4.34 -18.88% | USAR 22.58 13.18% | MARA 11.63 0.26% | SPY 708.72 -0.20% | PBM 11.3 48.68% | DRIP 5.16 -1.71% | CMPS 9.46 42.04% | ASTS 81 -5.30% | MRVL 147.84 5.83% | BTG 4.94 -1.20% | SRXH 0.1198 -5.67% | QBTS 21.655 -0.16% | ZSPC 1.54 2,400.00%

HCA Healthcare Raises Outlook After Q2 Earnings and Revenue Beat

HCA Healthcare (NYSE:HCA) reported second-quarter earnings that beat expectations, prompting the hospital operator to raise its full-year guidance.

Adjusted EPS came in at $6.84, topping estimates by $0.57, while revenue reached $18.61 billion, exceeding the $18.49 billion consensus.

Same-facility admissions rose 1.8%, and equivalent admissions increased 1.7% year-over-year. Emergency room visits rose 1.3%, while inpatient and outpatient surgeries dipped 0.3% and 0.6%, respectively. Revenue per equivalent admission grew 4.0% from the prior year.

HCA now expects 2025 revenue between $74.0 billion and $76.0 billion, up from its earlier range of $72.8 billion to $75.8 billion. Adjusted EBITDA is forecast at $14.7 billion to $15.3 billion, and diluted EPS is projected at $25.50 to $27.00, up from the previous $24.05 to $25.85 range.

Published on: July 25, 2025